[Elliptinium acetate and the nephrotic syndrome].
D000368:Aged; D000470:Alkaloids / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D004611:Ellipticines / Q000009:adverse effects*; D005260:Female; D006801:Humans; D009404:Nephrotic Syndrome / Q000139:chemically induced*
D000470:Alkaloids; D000970:Antineoplastic Agents; D004611:Ellipticines; C027767:elliptinium
Acétate d'elliptinium et syndrome néphrotique.